1. Kusamura S, Baratti D, Zaffaroni N, Villa R, Laterza B, Balestra MR, Deraco M. Pathophysiology and biology peritoneal carcinomatosis. World J Gastroenterol. 2010;2(1):12–8.
2. Yonemura Y, Nojima N, Kaji M, Fujimura T, Itoh H, Ninomiya I, Miyazaki I, Endo Y, Sasaki T. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer. 1995;76(6):941–53.
3. Shimoyama Y, Hirobashi S. Expression of E- and P-cadherin in gastric carcinoma. Cancer Res. 1991;51(8):2185–92.
4. Yasui W, Kuniyasu H, Akama Y, Kitahara K, Nagafuchi A, Ishihara S, Tsukita S, Tahara E. Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression. Oncol Rep. 1995;2(1):111–7.
5. Yasui W, Sano T, Nishimura K, Kitadai Y, Ji ZQ, Yokozaki H, Ito H, Tahara E. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer. 1993;54(1):49–52.